1. Home
  2. BNR vs JZ Comparison

BNR vs JZ Comparison

Compare BNR & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • JZ
  • Stock Information
  • Founded
  • BNR 2014
  • JZ 2011
  • Country
  • BNR China
  • JZ China
  • Employees
  • BNR N/A
  • JZ N/A
  • Industry
  • BNR Medical Specialities
  • JZ Other Consumer Services
  • Sector
  • BNR Health Care
  • JZ Real Estate
  • Exchange
  • BNR Nasdaq
  • JZ Nasdaq
  • Market Cap
  • BNR 29.1M
  • JZ 26.7M
  • IPO Year
  • BNR 2020
  • JZ 2022
  • Fundamental
  • Price
  • BNR $3.25
  • JZ $0.43
  • Analyst Decision
  • BNR
  • JZ
  • Analyst Count
  • BNR 0
  • JZ 0
  • Target Price
  • BNR N/A
  • JZ N/A
  • AVG Volume (30 Days)
  • BNR 68.1K
  • JZ 2.7M
  • Earning Date
  • BNR 06-02-2025
  • JZ 01-01-0001
  • Dividend Yield
  • BNR N/A
  • JZ N/A
  • EPS Growth
  • BNR N/A
  • JZ N/A
  • EPS
  • BNR N/A
  • JZ N/A
  • Revenue
  • BNR $70,669,261.00
  • JZ $34,090,704.00
  • Revenue This Year
  • BNR $136.32
  • JZ N/A
  • Revenue Next Year
  • BNR N/A
  • JZ N/A
  • P/E Ratio
  • BNR N/A
  • JZ N/A
  • Revenue Growth
  • BNR N/A
  • JZ N/A
  • 52 Week Low
  • BNR $2.18
  • JZ $0.34
  • 52 Week High
  • BNR $7.90
  • JZ $2.25
  • Technical
  • Relative Strength Index (RSI)
  • BNR 57.77
  • JZ 33.09
  • Support Level
  • BNR $2.49
  • JZ $0.39
  • Resistance Level
  • BNR $3.05
  • JZ $0.43
  • Average True Range (ATR)
  • BNR 0.34
  • JZ 0.14
  • MACD
  • BNR 0.15
  • JZ -0.00
  • Stochastic Oscillator
  • BNR 87.61
  • JZ 7.68

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

Share on Social Networks: